72 episodes

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Life Science Today Noah Goodson, PhD

    • Science
    • 5.0 • 7 Ratings

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

    Final Episode

    Final Episode

    This week, I have an announcement to make.

    Find out more at
    https://LifeScienceTodayPodcast.com


    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    • 4 min
    Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago

    Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago

    Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Sanofi/Takeda
    UniQure & CSL
    Fog Pharma
    Merck + Imago

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    • 8 min
    Indivior + Opiant, Regeneron + CytomX, Rezo, Provention

    Indivior + Opiant, Regeneron + CytomX, Rezo, Provention

    A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Indivior + Opiant
    Regeneron + CytomX
    Rezo
    Provention

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    • 6 min
    Intellia, Regeneron, Viatris + Oyster Point

    Intellia, Regeneron, Viatris + Oyster Point

    More CRISPR data, oncology wins, and a new player in ophthalmology

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Intellia
    Regeneron
    Viatris + Oyster Point

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    • 9 min
    Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye

    Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye

    Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Sumitovant + Myovant
    Thermo Fisher + Binding Site Group
    Astellas & Taysha
    Agios
    Vaxctye

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    • 8 min
    FDA, AbbVie + DJS, Roche + Hookipa, Kyverna

    FDA, AbbVie + DJS, Roche + Hookipa, Kyverna

    Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future.

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    FDA
    AbbVie + DJS
    Roche + Hookipa
    Kyverna

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    • 8 min

Customer Reviews

5.0 out of 5
7 Ratings

7 Ratings

ithinkitstartswithJ ,

Brilliant insights

Dr. Goodson holds your attention brilliantly through clear and direct information without sacrificing substance. His expertise is on display each episode through sound explanations of complex movements within the biotech and pharmaceutical worlds. This podcast is perfect for the novice as well as expert relating to these topics of discussion. I highly recommend this be a regular in your podcast rotation!

jec_c ,

Not only informative but also entertaining!

Dr Goodson brilliantly delivers scientific updates in a manner absent of confusing jargon, making it approachable to everyone. He also injects a bit of his educational discernment but still remains neutral. The short updates are perfect and I'm looking forward to more.

Bianca Sue ,

to the point

speaker is clear, easy to understand, length is good, content relevant. ads not intrusive

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Reinvent Yourself with Dr. Tara
Dr. Tara Swart Bieber
Radiolab
WNYC Studios
Something You Should Know
Mike Carruthers | OmniCast Media | Cumulus Podcast Network
Ologies with Alie Ward
Alie Ward
StarTalk Radio
Neil deGrasse Tyson